Aspire Real Estate Investors, Inc.

ASPI

US04538A1007

Delayed Nyse Other stock markets			5-day change	1st Jan Change
- ^USD	-.--%		-.--%	-

Dec. 17	ASP Isotopes Receives All Regulatory Approvals for Acquisition of Renergen	MT
Dec. 04	Cantor Fitzgerald Initiates Coverage on ASP Isotopes With Outperform Rating, $13 Price Target	MT

ASP Isotopes Says Paul Mann to Resume CEO Role in January

Published on 12/02/2025 at 10:29 am EST

MT Newswires

This article is reserved for members

Unlock the article: REGISTER NOW!

100% Free Registration

Already a customer? Log In

Latest news about Aspire Real Estate Investors, Inc.

Dec. 17	ASP Isotopes Receives All Regulatory Approvals for Acquisition of Renergen	MT
Dec. 04	Cantor Fitzgerald Initiates Coverage on ASP Isotopes With Outperform Rating, $13 Price Target	MT
Dec. 02	ASP Isotopes Says Paul Mann to Resume CEO Role in January	MT
Nov. 28	ASP Isotopes Extends Deadline to Meet Closing Conditions for Renergen Acquisition	MT
Nov. 07	ASP Isotopes Subsidiary Launches $64.3 Million Private Offering of Convertible Notes	MT
25-10-23	ASP Isotopes Unit Finalizes Purchase of One 30 Seven Assets	MT
25-10-15	ASP Isotopes Prices Public Offering of About 17 Million Shares	MT
25-10-14	ASP Isotopes Launches Public Offering; Shares Fall After-Hours	MT
25-10-13	ASP Isotopes Signs Silicon-28 Supply Deal, Acquires Radiopharmacy in Florida; Shares Rise Pre-Bell	MT
25-09-30	ASP Isotopes Receives Supply Order for Enriched Barium-137	MT
25-09-29	ASP Isotopes Says CEO Paul Mann to Take Temporary Leave; Robert Ainscow Named Interim CEO	MT
25-08-15	ASP Isotopes Sign MoU to Form Nuclear Fuels Joint Venture	MT
25-08-08	ASP Isotopes Gets Approval for Secondary Listing on Johannesburg Stock Exchange	MT
25-07-28	ASP Isotopes Invests $5 Million in Radiotherapeutic Development Firm IsoBio	MT
25-07-25	ASP Isotopes Says South Africa Antitrust Regulator Clears Offer for Renergen	MT
25-07-17	ASP Isotopes Expects to Ship Enriched Silicon-28 to First Customers in August	MT
25-07-11	ASP Isotopes' Proposed Acquisition Approved by Renergen Shareholders	MT
25-06-02	ASP Isotopes, Isotopia Enter Gadolinium-160 Supply Deal	MT
25-06-02	ASP Isotopes Prices $50 Million Direct Offering	MT
25-05-20	ASP Isotopes Agrees to Acquire Renergen; Shares Climb Pre-Bell	MT
25-05-19	ASP Isotopes, TerraPower Sign Loan, Supply Deals for Planned South Africa Facility -- Shares Jump After Hours	MT
25-04-24	ASP Isotopes Proposes Secondary Listing on Johannesburg Stock Exchange	MT
25-04-01	ASP Isotopes Begins Ytterbium-176 Production in South Africa	MT
25-03-27	ASP Isotopes Begins Producing Enriched Silicon-28 at South African Facility	MT
25-02-26	ASP Isotopes Starts Commercial Production of Enriched Carbon-14; Shares Rise	MT

Paul E.
Mann is the founder of ASP Isotopes, Inc., founded in 2021, serving as Executive Chairman since 2025.
Mr. Mann is the founder of Quantum Leap Energy LLC, founded in 2023, serving as Chairman since 2025.
Mr. Mann is also the founder of Varian Biopharma, Inc...
Mr. Mann is currently Chairman at Healthtech Solutions, Inc. since 2021.
Mr. Mann is Executive Chairman at Skyline Builders Group Holding Ltd. since 2026.
Mr. Mann is an Independent Director at Illumination Acquisition Corp.
I.
Former positions include Chairman at Varian Biopharmaceuticals, Inc. from 2020 to 2023.
Independent Non-Executive Director at Abeona Therapeutics, Inc. from 2020 to 2023.
Chief Financial Officer at RegenETP, Inc. from 2018 to 2020.
Executive Director at Morgan Stanley & Co. LLC in 2011.
Research Analyst at UBS Ltd. (Broker) from 2011 to 2012.
Research Analyst at UBS AG (Private Banking UK) from 2011 to 2012.
Analyst at Althea Capital LLP from 2012 to 2013.
Analyst at SFM UK Management LLP from 2013 to 2014.
Analyst at Deutsche Bank AG (Broker UK) in 2007.
Research Analyst at Morgan Stanley & Co. International Plc.
Manager-Healthcare Portfolio at Highbridge Capital Management LLC.
Analyst at Soros Fund Management LLC.
Research Scientist at Procter & Gamble Co. Education includes undergraduate and graduate degrees from the University of Cambridge.